Blood test for silica-related lung disease
Treatments studied
Part of Lungs & breathing clinical trials.
This study is looking for a new blood test that might help diagnose lung diseases caused by silica dust exposure at work. It will compare people who have had different levels of silica exposure to see if certain markers in the blood can signal lung damage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been exposed to silica dust at work (either low, moderate, or high levels – the study needs both groups)
- You are able to understand and agree to participate by signing a consent form
- You are affiliated with a social security system (health insurance)
- You do not have certain conditions that make breathing tests risky (like recent eye/throat surgery, heart attack, blood clot, uncontrolled high blood pressure, or collapsed lung)
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a new imaging technology called LIBS to examine lung tissue samples that were already removed as part of your regular care. The goal is to see if this method can help doctors better understand and diagnose chronic lung diseases like interstitial lung disease, sarcoidosis, or emphysema.
This study uses a simple breath test to detect different lung diseases. By analyzing the chemicals in your breath, researchers hope to find a faster, non-invasive way to diagnose lung conditions. It may be an option if you have a known lung disease and have a recent CT scan.
This trial uses a special blood test to find molecules that may show if lung cancer has spread through the bloodstream. The goal is to help doctors detect metastasis earlier.
This study is evaluating a blood-based test that might detect lung cancer early, before symptoms appear. Researchers are looking for heavy smokers who have no signs of cancer, as well as those with suspicious lung nodules or confirmed lung cancer, to see if a simple blood draw could help identify cancer sooner.
This trial studies blood and tissue samples from people with COPD, IPF, or lung cancer to find markers that can help diagnose and predict these conditions. It aims to discover why some lung diseases progress to cancer.
This study is testing a new blood test that looks for DNA from lung cancer cells in your blood. It aims to see if the test can find lung cancer early, even before symptoms start.
Hear when a new Exposure Occupational trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.